标题
Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors
作者
关键词
-
出版物
Journal of the American Chemical Society
Volume 145, Issue 1, Pages 385-391
出版商
American Chemical Society (ACS)
发表日期
2022-12-22
DOI
10.1021/jacs.2c10177
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rational Design for Nitroreductase (NTR)-Responsive Proteolysis Targeting Chimeras (PROTACs) Selectively Targeting Tumor Tissues
- (2022) Shi Shi et al. JOURNAL OF MEDICINAL CHEMISTRY
- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Radiotherapy Reduces N-Oxides for Prodrug Activation in Tumors
- (2022) Zexuan Ding et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Proteolysis-targeting chimeras (PROTACs) in cancer therapy
- (2022) Xinyi Li et al. Molecular Cancer
- Radiotherapy‐Induced Cleavage of Quaternary Ammonium Groups Activates Prodrugs in Tumors
- (2022) Zhibin Guo et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Radiation Cleaved Drug-Conjugate Linkers Enable Local Payload Release
- (2022) Jeremy M. Quintana et al. BIOCONJUGATE CHEMISTRY
- Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
- (2021) Adam D. Cotton et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Cancer Selective Target Degradation by Folate-Caged PROTACs
- (2021) Jing Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy
- (2021) Chi Zhang et al. Nature Communications
- Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer
- (2021) Shipeng He et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Switching on prodrugs using radiotherapy
- (2021) Jin Geng et al. Nature Chemistry
- Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians
- (2021) William A. Hall et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer
- (2021) Giulia Petroni et al. Nature Reviews Clinical Oncology
- Proteolysis‐targeting chimeras in drug development: A safety perspective
- (2020) Kevin Moreau et al. BRITISH JOURNAL OF PHARMACOLOGY
- Optical Control of Small Molecule-Induced Protein Degradation
- (2020) Yuta Naro et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Light-induced control of protein destruction by opto-PROTAC
- (2020) Jing Liu et al. Science Advances
- PHOTACs enable optical control of protein degradation
- (2020) Martin Reynders et al. Science Advances
- Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown
- (2020) Yu-Hui Jin et al. JOURNAL OF MEDICINAL CHEMISTRY
- External Radiation–Induced Local Hydroxylation Enables Remote Release of Functional Molecules in Tumors
- (2020) Qunfeng Fu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer
- (2019) María del Mar Noblejas-López et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Light-Induced Protein Degradation with Photocaged PROTACs
- (2019) Gang Xue et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeted protein degradation: expanding the toolbox
- (2019) Matthieu Schapira et al. NATURE REVIEWS DRUG DISCOVERY
- Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
- (2017) Xiangpeng Dai et al. NATURE MEDICINE
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- Self-Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol-Free Drugs
- (2015) Camilla Frich Riber et al. Advanced Healthcare Materials
- Disulfide-Cleavage-Triggered Chemosensors and Their Biological Applications
- (2013) Min Hee Lee et al. CHEMICAL REVIEWS
- Reductive activation of 5-fluorodeoxyuridine prodrug possessing azide methyl group by hypoxic X-irradiation
- (2011) Kazuhito Tanabe et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
- (2009) Teresa A. Soucy et al. NATURE
- Prodrugs: design and clinical applications
- (2008) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search